Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, H S AK, Meurer S, Deile M, Taye A, Knorr A, Lapp H, Müller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B, Müller-Esterl W, Schmidt HH.
Stasch JP, et al. Among authors: taye a.
J Clin Invest. 2006 Sep;116(9):2552-61. doi: 10.1172/JCI28371.
J Clin Invest. 2006.
PMID: 16955146
Free PMC article.